ARIX — Arix Bioscience Share News
0.000.00%
- £183.80m
- £82.85m
- £0.11m
Europe Research Roundup: Aviva, EasyJet, Next
Leads $58 Million Series A Investment Round For VelosBio
Brief: Iterum Begins Two Phase 3 Trials For Sulopenem
Brief: Arix Bioscience Says CEO Joe Anderson Will Transition To Chief Investment Officer
Brief: Arix Bioscience Completes 65 Mln Stg Series B Investment Round
Brief: Arix Bioscience Says Positive Clinical Progression In Group Businesses
Brief: Arix Bioscience Says Autolus Closes IPO
Brief: Evotec AG Forms Academic Bridge 'Lab591' With Arix Bioscience, Fred Hutchinson Cancer Research Center
Result of AGM
Brief: Arix Bioscience Updates On Iterum Proposed Nasdaq IPO
Update on Iterum proposed NASDAQ IPO
UK biotech firm Autolus joins CAR-T rush with Nasdaq IPO filing
Brief: Arix Bioscience Says Autolus Files for Proposed U.S. IPO
Autolus Files for Proposed US IPO
Arix notes Iterum?s proposed US IPO
Annual Results 2017
Notice of Annual Results
Arix to present at HC Wainwright on 10 April
Holding(s) in Company